MNDL Bio
MNDL Bio offers an AI-driven gene expression optimization platform that transitions companies from trial-and-error workflows to data-driven construct engineering. Their technology integrates advanced computational models and machine learning to maximize recombinant protein yield, going beyond traditional codon optimization methods. Key features include AI-driven codon optimization for improved translational efficiency, preservation of hidden genetic information, vector stability modeling, and translation dynamics optimization. The platform has demonstrated significant improvements for clients, including up to a 2.5-fold increase in enzyme expression and a 9.5- to 15-fold increase in protein expression for a 15 kDa protein in cell-free systems. MNDL Bio's technology is applicable across various sectors such as medical, agriculture, and pharmaceuticals, offering benefits like 50-90% lower cost of final product and 20-33% faster time to market, with a track record of 20 accomplished projects.
MNDL Bio
MNDL Bio offers an AI-driven gene expression optimization platform that transitions companies from trial-and-error workflows to data-driven construct engineering. Their technology integrates advanced computational models and machine learning to maximize recombinant protein yield, going beyond traditional codon optimization methods. Key features include AI-driven codon optimization for improved translational efficiency, preservation of hidden genetic information, vector stability modeling, and translation dynamics optimization. The platform has demonstrated significant improvements for clients, including up to a 2.5-fold increase in enzyme expression and a 9.5- to 15-fold increase in protein expression for a 15 kDa protein in cell-free systems. MNDL Bio's technology is applicable across various sectors such as medical, agriculture, and pharmaceuticals, offering benefits like 50-90% lower cost of final product and 20-33% faster time to market, with a track record of 20 accomplished projects.